
TVSF Phase 2 Award Announcement
The Ohio Third Frontier’s Technology Validation Start-up Fund has awarded a CSU spin out company, ComHealth Data Solutions, LLC, a $200,000 Phase 2 grant. ComHealth was founded by Dr. William Matcham, an associate professor in the School of Nursing, and is commercializing I-Hope, a Community Data Collection platform to digitize patient data collection by Community Health Workers in medically underserved areas.
The platform’s interoperability enables seamless data sharing with EMRs, health information exchanges, community organizations, and billing services—streamlining referrals, improving feedback, and enhancing whole-person care.
CSU’s Technology Transfer Office and the Entrepreneurs’ Center, which is the Dayton region’s Entrepreneurial Services Provider, were instrumental to ComHealth during the Phase 2 process. |
|

UPDATE: U.S. Patent Filing
U.S. Patent Application 19/184,214 was filed and titled Compositions and Methods for Modulating Cholesterol Efflux naming Dr. Kailash Gulshan, an assistant professor in the Department of Biology, Geology, and Environmental Science (BGES) and a member of the Center for Gene Regulation in Health and Disease (GRHD), as the inventor. The invention relates to a novel approach to prevent atherosclerosis. There is a significant need for technological advancements to enhance diagnosis and treatment of cardiovascular disease (CVD), high cholesterol, and atherosclerosis.
The general inventive concepts are based, in part, on the discovery that cholesterol efflux transporter ABCA1 can be induced, leading to an increase in the reverse cholesterol transport pathway. Such inducement leads to a reduction in cholesterol and attendant benefits for patients with CVD. |